Tacrolimus monotherapy in a patient with lupus flare using once-daily administration protocol

NDT Plus

Volumn 4, Issue 5, 2011, Pages 363-365

  Tanaka, Hiroshi ^a,b   Tsuruga, Kazushi ^b   Watanabe, Shojiro ^b   Aizawa Yashiro, Tomomi ^b   Chiba Fukada, Nao ^b   Ito, Etsuro ^b  

^a HIROSAKI UNIVERSITY   (Japan)

^b HIROSAKI UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; DOUBLE STRANDED DNA ANTIBODY; METHYLPREDNISOLONE; PREDNISOLONE; TACROLIMUS; VIDARABINE;

ADULT; ARTHRALGIA; CASE REPORT; CHRONIC DISEASE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOCAL GLOMERULOSCLEROSIS; HERPES VIRUS INFECTION; HUMAN; HUMAN TISSUE; HYPOCOMPLEMENTEMIA; KIDNEY BIOPSY; LETTER; LUPUS ERYTHEMATOSUS NEPHRITIS; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; PROTEINURIA; SIDE EFFECT; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 80053414666     PISSN: 17530784     EISSN: 17530792     Source Type: Journal    
DOI: 10.1093/ndtplus/sfr089     Document Type: Letter

References (10)

1. Kawai S, Yamamoto K. Safety of tacrolimus, an immunosuppressive agent, in the treatment of rheumatoid arthritis in elderly patients. Rheumatology (Oxford) 2006; 45: 441-444
2. Mok CC, Tong KH, To CH et al. Tacrolimus for induction therapy of diffuse proliferative lupus nephritis: an open-labeled pilot study. Kidney Int 2005; 68: 813-817 (Pubitemid 43323138)
3. Tse KC, Lam MF, Tang SCW et al. A pilot study on tacrolimus treatment in membranous or quiescent lupus nephritis with proteinuria resistant to angiotensin inhibitor or blockade. Lupus 2007; 16: 46-51 (Pubitemid 46178086)
4. Tanaka H, Oki E, Tsugawa K et al. Effective treatment of young patients with pediatric-onset, long-standing lupus nephritis with tacrolimus given as a single daily dose: an open-label pilot study. Lupus 2007; 16: 896-900 (Pubitemid 350157276)
5. Tanaka H, Oki E, Tsuruga K et al. Management of young patients with lupus nephritis using tacrolimus administered as a single daily dose. Clin Nephrol 2009; 72: 430-436
6. Asamiya Y, Uchida K, Otsubo S et al. Clinical assessment of tacrolimus therapy in lupus nephritis: one-year follow-up study in a single center. Nephron Clin Pract 2009; 113: c330-c336
7. Tanaka H, Tateyama T, Waga S. Methylprednisolone pulse therapy in Japanese children with severe lupus nephritis. Pediatr Nephrol 2001; 16: 817-819 (Pubitemid 32895611)
8. Mosca M, Bencivelli W, Vitali C et al. The validity of the ECLAM index for the retrospective evaluation of disease activity in systemic lupus erythematosus. Lupus 2000; 9: 445-450 (Pubitemid 30487428)
9. Duncan N, Dhaygude A, Owen J et al. Treatment of focal segmental glomerulosclerosis in adults with tacrolimus monotherapy. Nephrol Dial Transplant 2004; 19: 3062-3067 (Pubitemid 40057629)
10. Ikezumi Y, Kanno K, Koike H et al. FK506 ameliorate proteinuria and glomerular lesions induced by anti-Thy 1.1 monoclonal antibody 1-22-3. Kidney Int 2002; 61: 1339-1350 (Pubitemid 34304495)